Literature DB >> 25547548

Effects of sinus rhythm maintenance on left heart function after electrical cardioversion of atrial fibrillation: implications for tachycardia-induced cardiomyopathy.

Andreas J Zimmermann1, Matthias Bossard2, Stefanie Aeschbacher1, Tobias Schoen1, Gian Voellmin1, Yves Suter3, Anouk Lehmann1, Thomas Hochgruber1, Katrin Pumpol1, Christian Sticherling3, Michael Kühne3, David Conen1, Beat A Kaufmann4.   

Abstract

BACKGROUND: The role of tachycardia-induced cardiomyopathy vs tachycardia-related short diastolic filling period and reduced atrial contraction in decline of left ventricular ejection fraction (LVEF) in atrial fibrillation (AF) is uncertain. We aimed to characterize left heart changes over time in patients with AF who undergo electrical cardioversion (ECV).
METHODS: Consecutive AF patients who were to undergo ECV were enrolled. Patients with unstable or acute heart failure, severe valvular diseases, recent open-heart surgery, major disorders, or an unsuccessful ECV were excluded. Transthoracic echocardiography, including 3-dimensional left atrial and ventricular volume acquisitions, was performed 1-2 hours before and after ECV, and 4-6 weeks later.
RESULTS: In 73 patients (77% male, 66 ± 11 years), ECV resulted in an immediate increase in LVEF (from 43 [interquartile range (IQR), 33-50%] to 48 [IQR, 40-53%]; P < 0.0001). Four to 6 weeks after ECV, ejection fraction increased further in patients who remained in sinus rhythm (SR) (n = 55) to 55 (IQR, 44-62)%; P < 0.001. In patients with AF relapse, LVEF returned to values comparable to pre-ECV (n = 18) (44 [IQR, 32-51]%; P = 0.03). The atrial emptying fraction did not significantly change immediately after ECV (n = 69; from 20 [IQR, 13-25]% to 20 [IQR, 15-28]%; P = 0.14). Only patients who remained in SR showed an increase in atrial emptying fraction after 4-6 weeks (n = 51; to 37 [IQR, 26-48]%; P < 0.0001 vs post-ECV).
CONCLUSIONS: Immediate improvement in LVEF after ECV explains approximately 50% of total LVEF increase over time. However, in SR, LVEF, and atrial function continuously increase over 4-6 weeks after ECV. This might be attributable to recovery of tachycardia-induced cardiomyopathy.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25547548     DOI: 10.1016/j.cjca.2014.10.032

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  8 in total

Review 1.  Left ventricular ejection fraction as therapeutic target: is it the ideal marker?

Authors:  V Katsi; G Georgiopoulos; A Laina; E Koutli; J Parissis; C Tsioufis; P Nihoyannopoulos; D Tousoulis
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

2.  A case of fatal heart and liver failure accompanied by thyroid storm treated with prompt plasma exchange.

Authors:  Feibi Zeng; Tomofumi Takaya; Naofumi Yoshida; Tatsuro Ito; Makiko Suto; Yu Hatani; Hiroyuki Sano; Jun Ito; Hidenori Fukuoka; Tomoya Yamashita; Ken-Ichi Hirata
Journal:  J Cardiol Cases       Date:  2017-01-17

Review 3.  Significance and Management Strategies for Patients with Asymptomatic Atrial Fibrillation.

Authors:  Ewa Majos; Rafal Dabrowski
Journal:  J Atr Fibrillation       Date:  2015-02-28

4.  Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study.

Authors:  David M Charytan; Robert Foley; Peter A McCullough; John D Rogers; Peter Zimetbaum; Charles A Herzog; James A Tumlin
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-13       Impact factor: 8.237

5.  Determinants of Left Atrial Volume in Patients with Atrial Fibrillation.

Authors:  Matthias Bossard; Rahel Kreuzmann; Thomas Hochgruber; Philipp Krisai; Andreas J Zimmermann; Stefanie Aeschbacher; Katrin Pumpol; Arnheid Kessel-Schaefer; Frank-Peter Stephan; Nadja Handschin; Christian Sticherling; Stefan Osswald; Beat A Kaufmann; Guillaume Paré; Michael Kühne; David Conen
Journal:  PLoS One       Date:  2016-10-04       Impact factor: 3.240

6.  Post-cardioversion Improvement in LV Function Defined by 4D Flow Patterns and Energetics in Patients With Atrial Fibrillation.

Authors:  Lars Olof Karlsson; Hanna Erixon; Tino Ebbers; Ann Bolger; Carl-Johan Carlhäll
Journal:  Front Physiol       Date:  2019-05-29       Impact factor: 4.566

7.  Safety and efficacy of catheter ablation in atrial fibrillation patients with left ventricular dysfunction.

Authors:  Songbing Long; Yutao Xi; Lianjun Gao; Qi Chen; Jie Cheng; Yanzong Yang; Yunlong Xia; Xiaomeng Yin
Journal:  Clin Cardiol       Date:  2019-12-05       Impact factor: 2.882

Review 8.  Atrial fibrillation in heart failure: what should we do?

Authors:  Dipak Kotecha; Jonathan P Piccini
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.